LifeMD Inc Net Income
| LFMD Stock | USD 2.80 0.25 8.20% |
As of the 12th of February 2026, LifeMD secures the Standard Deviation of 5.29, mean deviation of 3.68, and Risk Adjusted Performance of (0.11). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LifeMD Inc, as well as the relationship between them. Please verify LifeMD Inc information ratio, as well as the relationship between the value at risk and kurtosis to decide if LifeMD Inc is priced some-what accurately, providing market reflects its recent price of 2.8 per share. Please also check out LifeMD jensen alpha, which is currently at (0.73) to check the company can sustain itself at a future point.
LifeMD Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.519 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -16.9 M | -17.7 M | |
| Net Loss | -43.8 M | -41.6 M | |
| Net Loss | -16.9 M | -17.7 M | |
| Net Loss | (0.53) | (0.55) | |
| Net Income Per E B T | 0.93 | 0.74 |
LifeMD | Net Income | Build AI portfolio with LifeMD Stock |
Analyzing LifeMD's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing LifeMD's current valuation and future prospects.
Latest LifeMD's Net Income Growth Pattern
Below is the plot of the Net Income of LifeMD Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in LifeMD Inc financial statement analysis. It represents the amount of money remaining after all of LifeMD Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is LifeMD's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LifeMD's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (18.73 M) | 10 Years Trend |
|
Net Income |
| Timeline |
LifeMD Net Income Regression Statistics
| Arithmetic Mean | (14,718,001) | |
| Coefficient Of Variation | (143.79) | |
| Mean Deviation | 16,264,262 | |
| Median | (1,240,827) | |
| Standard Deviation | 21,162,501 | |
| Sample Variance | 447.9T | |
| Range | 60.8M | |
| R-Value | (0.56) | |
| Mean Square Error | 330.2T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | (2,328,394) | |
| Total Sum of Squares | 7165.6T |
LifeMD Net Income History
Other Fundumenentals of LifeMD Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
LifeMD Net Income component correlations
LifeMD Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for LifeMD is extremely important. It helps to project a fair market value of LifeMD Stock properly, considering its historical fundamentals such as Net Income. Since LifeMD's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LifeMD's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LifeMD's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could LifeMD diversify its offerings? Factors like these will boost the valuation of LifeMD. Expected growth trajectory for LifeMD significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every LifeMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets | Return On Equity |
LifeMD Inc's market price often diverges from its book value, the accounting figure shown on LifeMD's balance sheet. Smart investors calculate LifeMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since LifeMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that LifeMD's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LifeMD represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LifeMD 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LifeMD's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LifeMD.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in LifeMD on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding LifeMD Inc or generate 0.0% return on investment in LifeMD over 90 days. LifeMD is related to or competes with High Tide, TruBridge, CVRx, Sanara Medtech, Senseonics Holdings, Sight Sciences, and 908 Devices. LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for ... More
LifeMD Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LifeMD's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LifeMD Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 28.11 | |||
| Value At Risk | (8.88) | |||
| Potential Upside | 8.55 |
LifeMD Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LifeMD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LifeMD's standard deviation. In reality, there are many statistical measures that can use LifeMD historical prices to predict the future LifeMD's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | 1.13 |
LifeMD February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 1.14 | |||
| Mean Deviation | 3.68 | |||
| Coefficient Of Variation | (671.36) | |||
| Standard Deviation | 5.29 | |||
| Variance | 27.97 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | 1.13 | |||
| Maximum Drawdown | 28.11 | |||
| Value At Risk | (8.88) | |||
| Potential Upside | 8.55 | |||
| Skewness | 0.6175 | |||
| Kurtosis | 1.74 |
LifeMD Inc Backtested Returns
LifeMD Inc has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12 % return per unit of risk over the last 3 months. LifeMD exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify LifeMD's Risk Adjusted Performance of (0.11), mean deviation of 3.68, and Standard Deviation of 5.29 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.7, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning LifeMD are expected to decrease at a much lower rate. During the bear market, LifeMD is likely to outperform the market. At this point, LifeMD Inc has a negative expected return of -0.68%. Please make sure to verify LifeMD's jensen alpha, kurtosis, price action indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if LifeMD Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.31 |
Below average predictability
LifeMD Inc has below average predictability. Overlapping area represents the amount of predictability between LifeMD time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LifeMD Inc price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current LifeMD price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
LifeMD Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, LifeMD Inc reported net income of (18.73 Million). This is 105.49% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.28% higher than that of the company.
LifeMD Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LifeMD's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LifeMD could also be used in its relative valuation, which is a method of valuing LifeMD by comparing valuation metrics of similar companies.LifeMD is currently under evaluation in net income category among its peers.
LifeMD ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, LifeMD's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to LifeMD's managers, analysts, and investors.Environmental | Governance | Social |
LifeMD Institutional Holders
Institutional Holdings refers to the ownership stake in LifeMD that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of LifeMD's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing LifeMD's value.| Shares | Jump Financial Llc | 2025-06-30 | 515.1 K | Two Sigma Investments Llc | 2025-06-30 | 450.5 K | Arrowstreet Capital Limited Partnership | 2025-06-30 | 434.9 K | Jpmorgan Chase & Co | 2025-06-30 | 412.6 K | Northern Trust Corp | 2025-06-30 | 376.1 K | Jane Street Group Llc | 2025-06-30 | 343.5 K | The Informed Momentum Company (formerly Eam Investors) | 2025-06-30 | 335.4 K | Amvescap Plc. | 2025-06-30 | 327.1 K | Qube Research & Technologies | 2025-06-30 | 309.3 K | Blackrock Inc | 2025-06-30 | 2.7 M | Vanguard Group Inc | 2025-06-30 | 2.1 M |
LifeMD Fundamentals
| Return On Equity | -22.43 | ||||
| Return On Asset | -0.0285 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 129.79 M | ||||
| Shares Outstanding | 48.14 M | ||||
| Shares Owned By Insiders | 15.03 % | ||||
| Shares Owned By Institutions | 42.64 % | ||||
| Number Of Shares Shorted | 4.91 M | ||||
| Price To Book | 111.90 X | ||||
| Price To Sales | 0.59 X | ||||
| Revenue | 212.45 M | ||||
| Gross Profit | 217.18 M | ||||
| EBITDA | (6.65 M) | ||||
| Net Income | (18.73 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 25.1 M | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | 17.51 M | ||||
| Short Ratio | 5.07 X | ||||
| Earnings Per Share | (0.25) X | ||||
| Target Price | 9.25 | ||||
| Number Of Employees | 304 | ||||
| Beta | 1.89 | ||||
| Market Capitalization | 146.81 M | ||||
| Total Asset | 72.46 M | ||||
| Retained Earnings | (236.25 M) | ||||
| Working Capital | (11.52 M) | ||||
| Net Asset | 72.46 M |
About LifeMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LifeMD Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LifeMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LifeMD Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Will Health Care Equipment & Supplies sector continue expanding? Could LifeMD diversify its offerings? Factors like these will boost the valuation of LifeMD. Expected growth trajectory for LifeMD significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every LifeMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets | Return On Equity |
LifeMD Inc's market price often diverges from its book value, the accounting figure shown on LifeMD's balance sheet. Smart investors calculate LifeMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since LifeMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that LifeMD's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LifeMD represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.